These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17641801)

  • 21. Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?
    Hameed DA; Abdel Raheem AM; Mosad E; Hammouda HM; Kamel NA; Abdel Aziz MA
    Urology; 2008 Aug; 72(2):374-8. PubMed ID: 18342927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion.
    Andius P; Johansson SL; Holmäng S
    Urology; 2007 Oct; 70(4):758-62. PubMed ID: 17991551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
    Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intra-epithelial carcinomatous lesions of the urinary bladder (author's transl)].
    Galian P; Desligneres S; Franc B; Abelanet R; Steg A
    Arch Anat Cytol Pathol; 1979; 27(3):187-93. PubMed ID: 507955
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bilateral obstructive uropathy as clinical presentation of primary bladder lymphoma].
    Herneández Alcara D; Gómez Pascual JA; Soler Martínez J; Vozmediano Chicharro R; Morales Jiménez P; Vivas Vargas E; Baena González V
    Arch Esp Urol; 2009 Apr; 62(3):230-2. PubMed ID: 19542597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder.
    Chen JC; Ho CL; Tsai HW; Tzai TS; Liu HS; Chow NH; Yang WH; Cheng HL
    Anticancer Res; 2008; 28(6B):4149-54. PubMed ID: 19192675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bladder tumors].
    Stenwig AE; Miller A; Poppe E
    Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1948-52. PubMed ID: 4767935
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoma-in-situ of the urinary bladder--histological and cytological observations.
    Schade RO
    Proc R Soc Med; 1967 Feb; 60(2):109-11. PubMed ID: 6018822
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary bladder adenocarcinoma arising in a spina bifida patient.
    Bitar M; Mandel E; Kirschenbaum AM; Unger PD
    Ann Diagn Pathol; 2007 Dec; 11(6):453-6. PubMed ID: 18022132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
    J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urinary bladder cancer producing granulocyte-colony stimulating factor: a case report and review of the literature].
    Yoshino T; Yoneda K
    Hinyokika Kiyo; 2008 Dec; 54(12):775-8. PubMed ID: 19175000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma.
    Paner GP; Ro JY; Wojcik EM; Venkataraman G; Datta MW; Amin MB
    Am J Surg Pathol; 2007 Sep; 31(9):1420-9. PubMed ID: 17721199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of variant histology on the outcome of bladder cancer treated with curative intent.
    Black PC; Brown GA; Dinney CP
    Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case report: urinoma as initial presenting sign of bladder malignancy.
    Rizvi S; Ibne A; Siddiqui MA; Syed M
    Indian J Cancer; 2011; 48(4):516-7. PubMed ID: 22293273
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.
    Tsui KH; Juang HH; Lee TH; Chang PL; Chen CL; Yung BY
    Acta Pharmacol Sin; 2008 Mar; 29(3):364-70. PubMed ID: 18298902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.